Peptide Knowledge Base · Immune
Thymalin: what it is, what the evidence says, and its real status
A thymic peptide preparation from the Khavinson school, claimed for immune restoration, limited independent validation.
Short version: a thymus-derived 'bioregulator' from the Khavinson canon, pitched for immune and aging support. Limited independent data; education only.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: Research-only · Education only.
Not offered, education only. Thymalin is a Khavinson-class thymic peptide with Russian-origin claims and limited independent validation. Not FDA-approved, not available.
How does Thymalin work?
A thymus-derived peptide preparation proposed to restore immune balance, in the Khavinson 'bioregulator' tradition.
What it does — and what it does not do
What it does: Claimed in Russian-origin work to support immune function in aging.
What it does not do: It is not independently validated, not approved, and not available.
How honest is the evidence?
Evidence grade D — Russian-origin claims; limited independent replication. Read our grading methodology for what each grade means.
What we still don't know: Independent replication is limited; outcomes unconfirmed.
WADA status: Not prohibited.
How it is taken
No established independent clinical dosing; research-stage.
Who should not take it
Not characterized in independent practice; no established safety profile.
Sources
Khavinson thymic-peptide literature (limited independent replication)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.